UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, ~~D.C.~~ DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

~~Pursuant~~PURSUANT toTO ~~Rule~~SECTION 13a-16 orOR 15d-16 OF THE

~~Under~~SECURITIES ~~the~~EXCHANGE ~~Securities~~ACT ~~Exchange~~OF ~~Act of~~ 1934

For the month of August 2009

Commission File Number: 0-29350

~~Vasogen~~VASOGEN ~~Inc~~INC. (Translation of registrant’s name into English) 2505 MEADOWVALE BOULEVARD MISSISSAUGA, ONTARIO L5N 5S2 (Address of principal executive offices)

~~(Translation~~Indicate ofby check mark whether the registrant’s ~~name~~files ~~into~~or ~~English)~~will file annual reports under cover Form 20-F or Form 40-F.

4Form ~~Robert~~20-F ~~Speck~~x ~~Parkway,~~Form ~~15th~~40-F ~~Floor, Mississauga, Ontario, L4Z 1S1~~ [_]

~~(Address~~Indicate ofby ~~principal~~check ~~executive~~mark ~~offices~~if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ~~_____~~____

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.SIGNATURES

Yes o No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VASOGEN INC. By: /s/ Graham Neil Name: Graham Neil Title: Vice-President, Finance and Chief Financial Officer

	ADVANTAGE ENERGY INCOME FUND (Registrant)
	By:	/s/ Graham Neil
Date: August 24, 2009		Name: Graham Neil Title: Vice President, Finance and Chief Financial Officer

Date: August 17, 2009

EXHIBIT LIST

Exhibit		Description
99.1		~~News~~Material ~~Release~~Change ~~dated~~Report ~~August~~on ~~17,~~Form ~~2009~~ 51-102F3, ~~Vasogen~~filed ~~Receives~~on ~~NASDAQ~~August ~~Notification~~24, ~~Related to Minimum Bid Price~~2009
99.2		~~News~~Arrangement ~~Release~~Agreement, dated August 1714, 2009, ~~Vasogen~~between ~~and~~Cervus ~~IntelliPharmaCeutics~~LP, toCervus ~~Combine~~GP toLtd ~~Create~~and ~~Publicly-traded~~Vasogen ~~Specialty Pharmaceutical Company~~Inc.
99.3		Arrangement Agreement, dated August 14, 2009, between Vasogen Inc., IntelliPharmaCeutics Corp. and IntelliPharmaCeutics Ltd.
99.4		Voting Agreement, dated August 14, 2009, between John Allport, IntelliPharmaCeutics Ltd. and Vasogen Inc.
99.5		Voting Agreement, dated August 14, 2009, between Peter Lacey and Vasogen Inc.
99.6		Voting Agreement, dated August 14, 2009, between IntelliPharmaCeutics Inc., IntelliPharmaCeutics Ltd. and Vasogen Inc.

Filing Compare · VASOGEN INC